Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Petit Patrice X

From Bioblast
Revision as of 09:56, 26 August 2013 by Bidaurratzaga Eider (talk | contribs) (Created page with "{{Person |lastname=Petit |firstname=Patrice X |title=Dr. |institution=Toxicologie, Pharmacologie et Signalisation Cellulaire INSERM S-747 Centre Universitaire des Saints-Père...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Name Petit Patrice X, Dr.
Institution Toxicologie, Pharmacologie et Signalisation Cellulaire

INSERM S-747

Centre Universitaire des Saints-Pères

Address 45 Rue des Saints-Pères, 75270
City Paris
State/Province
Country France
Email
Weblink
O2k-Network Lab


Labels:



Publications

 PublishedReference
BEC 2020.1 doi10.26124bec2020-0001.v12020Gnaiger E et al ― MitoEAGLE Task Group (2020) Mitochondrial physiology. Bioenerg Commun 2020.1. https://doi.org/10.26124/bec:2020-0001.v1

Abstracts

 PublishedReference
Petit 2019 MiP20192019
Patrice Petit
No abstract, Co-autor of Rainey 2019 MiP2019.
Rainey 2019 MiP20192019
Nathan Rainey
Mitochondria are not the primary target of curcumin-induced autophagy and apoptosis.
Petit 2018 MiP20182018
Patrice Petit
Decreasing cytosolic translation is beneficial to yeast and human Tafazzin-deficient cells with dirupted mitochondrial homeostasis (Barth syndrome cell model).
Petit 2017 MiP20172017
Patrice Petit
Barth syndrome cardiolipin alterations linked to tafazzin mutations lead to apoptosis and mitophygy alterations.
Petit 2013 Abstract MiP20132013Petit PX (2013) The cardiolipin defect linked to a tafazzin mutation in Barth syndrome disturbs mitochondrial metabolism, alters apoptosis and autophagic fluxes but does not affect cell cycle progression. Mitochondr Physiol Network 18.08.